GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
China Biologic Products Inc (CBPO) [hlAlert]

Rating:
Hold CBPO

China Biologic Products Inc (CBPO) downgraded to Hold by Aegis Capital

Posted on: Wednesday,  Nov 6, 2013  3:25 PM ET by Aegis Capital

Aegis Capital rated Hold China Biologic Products Inc (NASDAQ: CBPO) on 11/06/2013. Previously Aegis Capital rated Buy China
Biologic Products Inc (NASDAQ: CBPO) on 03/14/2013., when the stock price was $25.11. Since then, China Biologic Products Inc has gained 18.20% of its value until Aegis Capital rated CBPO Buy on 11/06/2013, when the price was $29.68. .

China Biologic Products, Inc. is a biopharmaceutical company and through its Chinese subsidiaries, Shandong Taibang and Qianfeng, and Huitian, the Company is engaged in the research, development and manufacturing of plasma-based pharmaceutical products in China. It sells human albumin, which represented approximately 49.7% during the year ended December 31, 2009. Human albumin is principally used to increase blood volume while immunoglobulin is used for certain disease preventions and cures. The Company sells human albumin 20%/10ml, 20%/25ml, 20%/50ml, 10%/10ml, 10%/25ml, 10%/50ml and 25%/50ml. It sells the products to customers in the People Republic of China (PRC), mainly hospitals and inoculation centers. In June 2009, it purchased 35% interest in Xi'an Huitian Blood Products Co., Ltd. On December 21, 2009, the Company established Logic Management and Consulting (China) Co., Ltd.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/8/2014 12:00 AM Buy
None
49.58 55.00
as of 12/13/2013
1 Week   
1 Month   
3 Months up  22.34 %
1 YTD up  18.19 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/6/2013 3:25 PM Hold
None
29.68
3/14/2013 10:25 AM Buy
None
25.11 28.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy